|
|
|
Company
Name |
Short
Summary |
| Cato
Research |
Cato Research is a global is
a full-service contract research and development
organization (CRO). |
| Celera |
Celera is a healthcare business that uses knowledge of human variability to provide new tests and services to personalize disease management.
|
| Cell
Genesys |
Cell
Genesys is focused on the development and commercialization
of gene therapies to treat major life-threatening
diseases, including cancer and cardiovascular
disease. |
| Cytokinetics |
Cytokinetics
is focused on the complementary missions of drug
discovery and the commercialization of novel cellular
bioinformatics technologies. |
| DiaDexus |
DiaDexus
is a company formed as a joint venture between
SmithKline Beecham Corp. and Incyte Pharmaceuticals,
Inc., dedicated to the discovery and commercialization
of novel molecular diagnostics. |
| Exelixis |
Exelixis
is a rapidly growing, well-funded, privately held
biopharmaceutical company whose mission is to
identify novel therapeutic targets for drug discovery
by elucidating the biochemical pathways involved
in human diseases. |
| FibroGen |
FibroGen
is a biotechnology company focusing on the development
of innovative recombinant human/animal collagen
biomaterials and novel anti-fibrotic pharmaceuticals. |
| Genentech |
Genentech,
Inc. is a leading biotechnology company using
human genetic information to develop, manufacture
and market biopharmaceuticals that address significant
unmet medical needs. |
| Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
| Rigel |
Rigel
employs a set of unique technologies in the rapid
discovery and validation of novel pharmaceutical
targets, as well as in the design of therapeutic
agents which regulate the function of these targets
in specific disease processes. |
| Sunesis
Pharmaceuticals |
Sunesis
Pharmaceuticals is committed to becoming a leader
in the discovery of important new pharmaceutical
products for the treatment of human disease. They
are doing this by applying a revolutionary new
approach to drug discovery that is based on a
novel chemical methodology combined with critical
insights into the nature of molecular recognition
between natural macromolecules and their substrates
or ligands. |
| Titan
Pharmaceuticals |
Titan
Pharmaceuticals develops products for the treatment
of cancer and central nervous system disorders. |
